诺丁汉大学的试验发现，LSVT LOUD 对帕金森患者的声音问题比 NHS 语言治疗更有效。 University of Nottingham trial finds LSVT LOUD more effective than NHS speech therapy for Parkinson's voice problems.

由诺丁汉大学专家领导的重大临床试验表明，李·西尔弗曼语音治疗（LSVT LOUD）对帕金森病患者比现行 NHS 言语和语言治疗更有效。 Major clinical trial led by University of Nottingham experts reveals Lee Silverman Voice Treatment (LSVT LOUD) to be more effective than current NHS speech and language therapy for Parkinson's patients. 与无言语和语言治疗以及 NHS 提供的言语和语言治疗相比，LSVT LOUD 减少了患者报告的声音问题的影响。 LSVT LOUD reduces patients' reported impact of voice problems, compared to no speech and language therapy and NHS delivered speech and language therapy. 该试验由 NIHR HTA 资助，涉及 40 个 NHS 言语和语言治疗中心，并发表在《BMJ》上。 The trial, funded by NIHR HTA, involved 40 NHS speech and language therapy centres and was published in The BMJ.